Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Ibogaine HydrochlorideRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2
2
67%
Phase 1/2
1
33%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1/2Combined phases
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 1/21 (33.3%)
Phase 22 (66.7%)

Trials by Status

completed267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_1_2

Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder

NCT07871877
completedphase_2

Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification

NCT04003948
completedphase_2

Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial

NCT03380728

Clinical Trials (3)

Showing 3 of 3 trials
NCT07871877Phase 1/2

Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder

Not Yet Recruiting
NCT04003948Phase 2

Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification

Completed
NCT03380728Phase 2

Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial

Completed

All 3 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
3